Clinical Trial Update: RAD001, FOLFOX and Bevacizumab in Treatment of Colorectal Carcinoma [Phase 1, Phase 2]

View source ↗

Summary

Completed Phase 1/2 clinical trial evaluating the combination of everolimus (RAD001), FOLFOX chemotherapy, and bevacizumab in colorectal cancer, with results po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• Adrucil (5-fluorouracil)
• Afinitor (everolimus)
• Avastin (bevacizumab)
• Eloxatin (oxaliplatin)
• Leucovorin (folinic acid)

Snippet

Sponsor: University of Utah | Conditions: Colorectal Cancer | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2017-03-06